3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Ewing
1
Lymphoproliferative Disorders
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Acute
1
Interventions
venetoclax
15
ibrutinib
12
Rituximab
10
Cyclophosphamide
10
obinutuzumab
9
acalabrutinib
8
Specimen Handling
8
Biopsy
7
pirtobrutinib
6
zanubrutinib
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Magnetic Resonance Spectroscopy
4
Lenalidomide
4
ARQ531
4
idelalisib
3
Vincristine
3
Prednisone
3
Doxorubicin
3
Cyclosporine
3
Bendamustine Hydrochloride
3
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
CT-P10
2
treosulfan
1
tocilizumab
1
pembrolizumab
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
etoposide phosphate
×
30 days
×
Clear all
No trials found.